Vaccines and drugs under clinical trials for prevention and treatment of COVID-19.
Ontology highlight
ABSTRACT: The uncertainty related to prevention and treatment of Coronavirus disease 2019 due to lack of effective vaccine candidates or drug molecules has resulted in extensive spread of infection and mortality worldwide. Although the asymptomatic or mild patients are becoming healthy with regular over-the-counter medicines and proper rest and care, for the severe patients, in the absence of definite cure, different drug combinations are being used to treat on trial basis without the assurance of efficacy and safety. This scenario has however changed now with some medicines including antiviral Remdesivir and Favipiravir and anti-inflammatory drugs like dexamethasone and tocilizumab which have shown some positive results in trials such as decreasing need of mechanical or non-invasive ventilation or
SUBMITTER: Yadav UCS
PROVIDER: S-EPMC7984501 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA